- Presentations
- 5
- Markets
- 1
Xtampza ER is a brand of Oxycodone marketed by Collegium Pharmaceutical, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Oxycodone
- Brand owner
- Collegium Pharmaceutical
- Registered in
- United States
- Strengths and forms
- 13.5 mg extended-release capsule, 18 mg extended-release capsule, 27 mg extended-release capsule, 36 mg extended-release capsule, 9 mg extended-release capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Xtampza ER 13.5 mg extended-release capsuleOral | Collegium Pharmaceutical | US FDA | Available on request |
| Xtampza ER 18 mg extended-release capsuleOral | Collegium Pharmaceutical | US FDA | Available on request |
| Xtampza ER 27 mg extended-release capsuleOral | Collegium Pharmaceutical | US FDA | Available on request |
| Xtampza ER 36 mg extended-release capsuleOral | Collegium Pharmaceutical | US FDA | Available on request |
| Xtampza ER 9 mg extended-release capsuleOral | Collegium Pharmaceutical | US FDA | Available on request |
Equivalent brands
Other brands of Oxycodone.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Xtampza ER
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.